Nutra Pharma Corp. Letter to Shareholders

Nutra Pharma Corporation , a biotechnology company that is developing treatments for Multiple Sclerosis , Human Immunodeficiency Virus , Adrenomyeloneuropathy and Pain, announced today that the Company's Chief Executive Officer, Rik J Deitsch, had published a Shareholder Letter on the Company's website.

http://www.biospace.com/news_story.aspx?StoryID=309751&full=1